Vericel Corp. (VCEL)
35.25
+1.48
(+4.38%)
USD |
NASDAQ |
Apr 17, 10:42
Vericel Cash from Investing (Quarterly) : -16.39M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | -1.588M |
| Marker Therapeutics, Inc. | 0.00 |
| Moderna, Inc. | -48.00M |
| Krystal Biotech, Inc. | 11.16M |
| Tenaya Therapeutics, Inc. | -0.067M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 15.01M |
| Cash from Financing (Quarterly) | 1.065M |
| Free Cash Flow | 24.75M |
| Free Cash Flow Per Share (Quarterly) | 0.2463 |
| Free Cash Flow to Equity (Quarterly) | 14.36M |
| Free Cash Flow to Firm (Quarterly) | 12.98M |
| Free Cash Flow Yield | 1.37% |